Histopathological Assessment of Endoscopic Gastric Mucosal Biopsies of Patients Attending a Tertiary Care Hospital
Rajendra Maharjan1,2 Ashish Rouniyar1,3*
¹Department of Pathology, Manipal College of Medical Sciences, Pokhara, Nepal
²Department of Pathology, Nepal Armed Police Force Hospital, Kathmandu, Nepal
³Department of Microbiology, Nepal Police Hospital, Kathmandu, Nepal
*Corresponding author
*Aashish Gupta, Department of Microbiology, Nepal Police Hospital, Kathmandu, Nepal.
DOI: 10.55920/JCRMHS.2025.09.001386
UGI*=upper gastrointestinal tract
Table 1: Histopathological diagnoses based on clinical presentations, endoscopic findings, and provisional endoscopic diagnosis
UGI*=upper gastrointestinal tract
Among the patients undergoing histopathological assessments, 40 (50.0%) were diagnosed with chronic gastritis, 23 (28.75%) with low-grade dysplasia, 15 (18.75%) with adenocarcinoma, and 2 (2.50%) with high-grade dysplasia. Dyspepsia was the chief clinical complaint for all patients with any histopathological diagnosis. Weight loss was reported by 8 (30.77%) patients with low-grade dysplasia and 14 (53.85%) patients with adenocarcinoma. Anorexia, abdominal pain, or upper gastrointestinal bleeding were not clinical complaints in patients with high-grade dysplasia (Table 2).
The endoscopic findings included 29 (36.25%) ulcers, 24 (30.0%) cases of erythema, and 13 (16.25%) cases of atrophy. Erythema was most frequently observed in patients diagnosed with chronic gastritis (79.17%), while atrophy (46.15%) and growth (100%) were noted in patients with low-grade dysplasia and adenocarcinoma, respectively. Each patient with high-grade dysplasia showed an ulcer (3.45%) and atrophy (7.69%) on endoscopy (Table 2).
The provisional endoscopic diagnosis of chronic gastritis identified 20 (71.43%) patients with gastritis, 11 (55.0%) with benign gastric ulcers, and 9 (28.13%) with malignancy. Of those initially diagnosed with adenocarcinoma, 12 (37.50%) and 10 (31.25%) patients were classified as malignant based on provisional endoscopy. Additionally, 10 (31.25%) patients initially diagnosed with adenocarcinoma and 7 (25.0%) with low-grade dysplasia were reclassified as having gastritis (Table 2).


